Invention Grant
- Patent Title: Compositions for the treatment of Fragile X syndrome
-
Application No.: US14128154Application Date: 2012-06-19
-
Publication No.: US10435366B2Publication Date: 2019-10-08
- Inventor: Sylvain Briault , Olivier Perche
- Applicant: Sylvain Briault , Olivier Perche
- Applicant Address: FR Paris FR Orleans FR Orleans
- Assignee: Centre National de la Recherche Scientifique,Centre Hospitalier Regional d'Orleans,University d'Orleans
- Current Assignee: Centre National de la Recherche Scientifique,Centre Hospitalier Regional d'Orleans,University d'Orleans
- Current Assignee Address: FR Paris FR Orleans FR Orleans
- Agency: Morgan, Lewis & Bockius LLP
- Priority: EP11171532 20110627
- International Application: PCT/IB2012/053089 WO 20120619
- International Announcement: WO2013/001412 WO 20130103
- Main IPC: A61K31/404
- IPC: A61K31/404 ; C07D209/34
Abstract:
The present invention relates to a composition comprising a maxi-K potassium channel opener the use in the treatment of fragile X syndrome. More specifically the present invention relates to a composition comprising a fluoro-oxindole or a chloro-oxindole for use in the treatment of fragile X syndrome.
Public/Granted literature
- US20140221450A1 Compositions for the treatment of Fragile X syndrome Public/Granted day:2014-08-07
Information query
IPC分类:
